Drug
Foscarbidopa clinical trials
How studies write it
Studies that test it under each name
Written with another drug
- ABBV-951
- 7
Studies by the year they started
7 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Dopamine Agonists source
Studies
Open first, then newest update. How each study uses foscarbidopa is read from its arms, and is right about nine times in ten.
Testing it · 7
- Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseCompletedPhase 3AbbVieNCT04750226Written as ABBV-951
- Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's DiseaseCompletedPhase 3AbbVieNCT04379050Written as ABBV-951
- A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient EnvironmentCompletedPhase 1AbbVieNCT03374917Written as ABBV-951
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's DiseaseCompletedPhase 1AbbVieNCT03033498Written as ABBV-951
- A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)CompletedPhase 3AbbVieNCT03781167Written as ABBV-951
- Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's DiseaseCompletedPhase 1AbbVieNCT05094050Written as ABBV-951
- Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseCompletedPhase 3AbbVieNCT04380142Written as ABBV-951
Codes
What other systems call foscarbidopa · ClinicalTrials.gg INT015095
- UNII (FDA) 5NT8HCA4OOFOSCARBIDOPAConfirmed FDA, Wikidata
- Wikidata Q76854547foscarbidopaConfirmed FDA, Wikidata
- NCI Thesaurus C166853FoscarbidopaOne source FDA
- DrugBank DB16171One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5NT8HCA4OO | FOSCARBIDOPA | Confirmed FDA, Wikidata |
| Wikidata | Q76854547 | foscarbidopa | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166853 | Foscarbidopa | One source FDA |
| DrugBank | DB16171 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.